Geron Corporation [NASDAQ: GERN] jumped around 0.13 points on Tuesday, while shares priced at $3.40 at the close of the session, up 3.98%. The company report on January 19, 2023 that Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 75,730 shares of Geron common stock as inducements to a newly hired employee in connection with commencement of employment with the Company.
The stock options were granted on January 18, 2023 at an exercise price of $3.12 per share, which is equal to the closing price of Geron common stock on the date of grant. A stock option representing an aggregate of 70,000 shares has a 10-year term and vests over four years, with 12.5% of the shares underlying the option vesting on the six-month anniversary of commencement of employment for the employee and the remaining shares vesting over the following 42 months in equal installments of whole shares, subject to continued employment with Geron through the applicable vesting dates. Stock options representing an aggregate of 5,730 shares have a 10-year term and vest in full upon achievement of certain regulatory milestones, subject to continued employment with Geron through the applicable vesting dates. All of the stock options were granted as material inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4) and are subject to the terms and conditions of the stock option agreements covering the grants and Geron’s 2018 Inducement Award Plan, which was adopted December 14, 2018 and provides for the granting of stock options to new employees.
Geron Corporation stock is now 40.50% up from its year-to-date (YTD) trading value. GERN Stock saw the intraday high of $3.43 and lowest of $3.24 per share. The company’s 52-week high price is 3.84, which means current price is +45.30% above from all time high which was touched on 01/04/23.
Compared to the average trading volume of 8.29M shares, GERN reached a trading volume of 7130804 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Geron Corporation [GERN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GERN shares is $5.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GERN stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wedbush have made an estimate for Geron Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 28, 2022. While these analysts kept the previous recommendation, B. Riley Securities raised their target price to Buy. The new note on the price target was released on July 28, 2022, representing the official price target for Geron Corporation stock. Previously, the target price had yet another raise to $4, while Robert W. Baird analysts kept a Outperform rating on GERN stock.
The Average True Range (ATR) for Geron Corporation is set at 0.25, with the Price to Sales ratio for GERN stock in the period of the last 12 months amounting to 831.64. The Price to Book ratio for the last quarter was 12.59, with the Price to Cash per share for the same quarter was set at 0.53.
How has GERN stock performed recently?
Geron Corporation [GERN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.26. With this latest performance, GERN shares gained by 63.46% in over the last four-week period, additionally plugging by 83.78% over the last 6 months – not to mention a rise of 223.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GERN stock in for the last two-week period is set at 67.61, with the RSI for the last a single of trading hit 70.38, and the three-weeks RSI is set at 65.50 for Geron Corporation [GERN]. The present Moving Average for the last 50 days of trading for this stock 2.48, while it was recorded at 3.21 for the last single week of trading, and 2.06 for the last 200 days.
Geron Corporation [GERN]: Deeper insight into the fundamentals
Geron Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.70 and a Current Ratio set at 2.70.
Earnings analysis for Geron Corporation [GERN]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GERN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Geron Corporation go to 5.00%.
Insider trade positions for Geron Corporation [GERN]
There are presently around $646 million, or 50.50% of GERN stock, in the hands of institutional investors. The top three institutional holders of GERN stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 30,126,299, which is approximately 0% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 26,616,761 shares of the stock with an approximate value of $90.5 million in GERN stocks shares; and VANGUARD GROUP INC, currently with $62.03 million in GERN stock with ownership of nearly -7.527% of the company’s market capitalization.
Positions in Geron Corporation stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 104 institutional holders increased their position in Geron Corporation [NASDAQ:GERN] by around 17,280,986 shares. Additionally, 44 investors decreased positions by around 21,644,730 shares, while 50 investors held positions by with 150,934,505 shares. The mentioned changes placed institutional holdings at 189,860,221 shares, according to the latest SEC report filing. GERN stock had 44 new institutional investments in for a total of 10,182,251 shares, while 13 institutional investors sold positions of 1,460,139 shares during the same period.